Agencies spar over vaccine trial

Article Abstract:

Politics, economics and science are all involved in the question of how to spend the $20 million appropriated to test AIDS vaccines. The Department of Health and the National Institutes of Health disagree on whether multi-vaccines should be tested.

---

Lobbying for an AIDS trial

Article Abstract:

MicroGeneSys Inc successfully lobbied Congress for an appropriations bill funding the testing of its AIDS vaccine gp160. AIDS researchers are outraged by the attempt to bypass peer review in the decision to test the therapeutic vaccine.

Political activity, Vaccines industry, Biological products industry, Science and technology policy, United States. Congress

---

MicroGeneSys withdraws from trial

Article Abstract:

Critics charge that MicroGeneSys has decided not to allow its VaxSyn AIDS vaccine be tested in a government-sponsored trail because the biotechnology firm is concerned about how its vaccine will compare to those made by competitors.

Research, Biotechnology industry, Biotechnology industries

Similar abstracts:

• Abstracts: Mechanics and Physics of brittle to ductile transitions in fracture. The modeling of unusual rate sensitivities inside and outside the dynamic stain aging regime
• Abstracts: Seventh AIDS conference: mostly ''fine tuning''. Clinton holds first AIDS summit
• Abstracts: Laser microprobe mass analysis of individual North Sea aerosol particles. Characterization of individual giant aerosol particles above the North Sea
• Abstracts: Supercritical carbon dioxide extraction of organics from soil. Investigation of adsorption equilibria of volatile organics on soil by frontal analysis chromatography
• Abstracts: Underwater wizardry: we dive with a dazzling camera to test its mettle. Digital photography

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.